PHAR: Pharming Sotuvga nisbatan narx
Pharming Group N.V. patent himoyasi va irsiy angioedemani davolash vositalari savdosiga tayanadi, garchi kompaniya hozirda yangi immun dori vositalari orqali yagona mahsulotga bo'lgan bog'liqligini muvaffaqiyatli kamaytirayotgan bo'lsa-da. Kompaniyaning harakatlanuvchi P/S ko'rsatkichi ushbu transformatsiyani vizuallashtiradi va ushbu ko'rsatkich 2.40 ga yetdi. Tadqiqot markazlari bilan strategik ittifoqlar va terapiya usullarini litsenziyalash kamyob kasalliklar dori vositalarining global bozorga kirishini tezlashtirmoqda.
Pharming (PHAR) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Pharming Group N.V.|PHAR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Pharming Corp|PHAR - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Pharming|PHAR - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Pharming Group|Shoshilinch likvidlik koeffitsiyenti pharming.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
PHAR - Sof foyda|Prognoz qilingan sof foyda Pharming Group N.V.|PHAR - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Pharming Group NV|PHAR - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati multiplikatori Pharming|PHAR - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Pharming Group|PHAR - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi pharming.com|PHAR - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Pharming Group N.V.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:PHAR (pharming.com)
Pharming Group N.V. (PHAR) barqarorligi sug'urta kompaniyalarining noyob patologiyalarni davolashda qo'llaniladigan qimmatbaho dori vositalariga bo'lgan doimiy talabiga asoslangan. P/S koeffitsiyenti bozor kapitalizatsiyasini yillik daromad bilan solishtiradi, bu esa sotuvlar nisbatidagi narx tendentsiyasi aktivning haddan tashqari qimmat baholanganlik darajasini aniqlash va patentlangan biologik ishlanmalarni monetizatsiya qilishning uzoq muddatli samaradorligini baholash imkonini beradi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Narxning sotuvga nisbati PTGX|IMVT: P/S multiplikatori|kiniksa.com - Bozor kapitallashuvining daromadga nisbati|GRFS (Grifols) - P/S multiplikatori|P/S multiplikatori Adaptive Biotech|Narxning daromadga nisbati Celldex (CLDX)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati BioCryst BCRX|VERA - Kapitalizatsiyaning daromadga nisbati|Dianthus Therapeutics, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Pharvaris NV PHVS|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati TRML|PGEN (Precigen, Inc.) - P/S multiplikatori|NKTR - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati UPB (Upstream Bio)|ZBIO (Zenas Bio) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori IMNM (Immunome Corp)|Narx/daromad multiplikatori Gossamer Bio Corp.|KALV - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati SEPN (septerna.com)|Pieris Pharmaceuticals, Inc. (PVLA) - Narxning daromadga nisbati|Sotuvga nisbatan narx Savara Inc (SVRA)|Kapitalizatsiyaning daromadga nisbati RIGL|P/S multiplikatori AnaptysBio Inc.|Narxning daromadga nisbati Astria Therapeutics (ATXS)|ENGN: Narxning sotuvga nisbati|RAPT Therapeutics - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati JBIO|ACRS - Narxning daromadga nisbati|KYTX (Kyverna Therapeutics, Inc) - Kapitalizatsiya va daromad nisbati|TLSA (Tiziana Life Sciences) - Kapitalizatsiyaning daromadga nisbati|CABA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati VTYX|Narxning daromadga nisbati THTX|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics Inc.)|Narx/daromad koeffitsiyenti Eledon Pharmaceuticals, Inc|Narxning daromadga nisbati Agenus AGEN|CLYM (climbbio.com) - Narxning sotuvga nisbati|Zura Bio - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ATYR (aTyr Pharma Inc)|ADAG: P/S multiplikatori|Ikena Oncology (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Labs Inc|EQ: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Connect Biopharma (CNTB)|IMUX: Narxning sotuvga nisbati|P/S multiplikatori ATRA (Atara Bio)|Bozor kapitallashuvining daromadga nisbati IFRX|X4 Pharmaceuticals - P/S multiplikatori|ACET - P/S multiplikatori|celularity.com (CELU) - Narxning daromadga nisbati|INmune Bio Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Barinthus Bio|Kapitalizatsiyaning daromadga nisbati Kezar Life Sciences Inc (KZR)|P/S multiplikatori SABS|P/S multiplikatori akaritx.com (AKTX)|Enlivex Therapeutics Ltd. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati QTTB|GeoVax Labs Inc - P/S multiplikatori|Narx/daromad koeffitsiyenti Edesa Biotech Corp EDSA|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Carisma Therapeutics Inc.|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiyaning daromadga nisbati Bolt Bio (BOLT)|Kapitalizatsiyaning daromadga nisbati HCWB (HCW Biologics Inc.)|P/S multiplikatori aptevotherapeutics.com (APVO)|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX: Kapitalizatsiya va daromad nisbati|GRI Bio - P/S multiplikatori|Sotuvga nisbatan narx XORTX Therapeutics Inc|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Narxning sotuvga nisbati REVB (Revelation Biosciences Corp)|INDP (Indaptus Therapeutics) - P/S multiplikatori|SCNI: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CALI|P/S multiplikatori affimed.com (AFMD)|Narxning daromadga nisbati Allakos ALLK|Bozor kapitallashuvining daromadga nisbati HOOK|IGMS - Narxning daromadga nisbati|iteostherapeutics.com (ITOS) - Kapitalizatsiyaning daromadga nisbati|OCEA: P/S multiplikatori|TCBP - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Third Harmonic Bio, Inc
